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Wnt signaling plays critical biological roles during normal
embryonic development andhomeostasis in adults. In the canonical
pathway, binding of Wnt ligands to the Frizzled (Fzd) receptor and
the low density lipoprotein-related receptor (LRP) 5 or LRP6 core-
ceptor initiates downstream signaling events leading to gene activa-
tion by -catenin and the T-cell factor (TCF)-lymphoid enhancer
factor (LEF) family transcription factor complex. In this study, we
provide several lines of evidence that the mouse Cristin/R-spondin
family proteins function as Fzd8 and LRP6 receptor ligands and
induce the canonical Wnt/-catenin signaling pathway, leading to
TCF-dependent gene activation. First, conditioned medium con-
taining Cristin/R-spondin proteins effectively induced reporter
activity in a TCF-binding site-dependent manner. Second, stimula-
tion of cells with Cristin/R-spondin was accompanied by stabiliza-
tion of endogenous -catenin proteins and induction of canonical
Wnt target genes. Third, Cristin/R-spondin proteins physically
interacted with the extracellular domains of the LRP6 and Fzd8
receptors in vivo and in vitro. Interestingly, unlike canonical Wnt
ligands, Cristin/R-spondin failed to form a ternary complex with
both LRP6 and Fzd8 receptors, suggesting that R-spondinmay acti-
vate the canonicalWnt signaling pathway by differentmechanisms.
Furthermore, Cristin/R-spondin proteins possess an intriguing
positive modulatory activity on Wnt ligands, possibly through a
direct interaction. Our findings expand the repertoire of ligands
that induce -catenin/TCF-dependent gene activation and impli-
cate the presence of active-catenin-dependent gene activation in a
Wnt-free biological context.
Wnt signaling is one of the key signaling pathways controlling cell
proliferation, differentiation, andmorphogenesis during embryogenesis
and in adults (1, 2). Wnt ligands are secreted glycoproteins and induce
multiple intracellular signaling pathways (3–7). In the canonical path-
way, Wnt ligands bind to the Frizzled (Fzd)2 family receptors and their
low density lipoprotein receptor-related protein (LRP) 5 or LRP6 core-
ceptor, leading to recruitment of Dishevelled (Dvl) and Axin proteins
from the cytoplasm to the receptors on the plasma membrane (6). Sub-
sequently, the activities of glycogen synthase kinase-3 and casein
kinase I are inhibited. As a result, -catenin proteins, which are nor-
mally phosphorylated by these kinases and degraded in the absence of
Wnt stimulation, become underphosphorylated and escape from the
degradation pathway. Accumulated -catenin proteins in the cyto-
plasm are eventually translocated into the nucleus, where they are
engaged in gene activation as a complex with T-cell factor (TCF) family
transcription factors. Additionally, Wnt ligands also induce -catenin-
independent intracellular signaling pathways, including theWnt/Ca2,
Wnt/cGMP, and planar cell polarity pathways, in which only the Fzd
receptors, not the LRP5 or LRP6 coreceptor, are required (4, 7).
Recent discoveries changed the conventional view ofWnt ligands and
Fzd/LRP receptors (8–11). Norrin, a secreted protein unrelated to the
Wnt proteins, is encoded by the Norrie disease gene, which is respon-
sible for human hereditary Norrie disease, which is associated with
blindness, deafness, and mental retardation (12, 13). Recently, Norrin
was discovered as a high affinity ligand specific for the Fzd4LRP6 recep-
tor complex, which induces -catenin-dependent signaling (8). The
RYK, Derailed, and LIN-18 proteins, receptor tyrosine kinases with
unknown function, were determined to be novel Wnt receptors in
mouse, Drosophila, and Caenorhabditis elegans, respectively (9–11).
These discoveries expanded the repertoire of ligands and receptors
involved in Wnt/Fzd/LRP signaling and suggest the possibility of
unknown ligands unrelated to theWnt proteins and receptors unrelated
to Fzd and LRP5 or LRP6.
We provide evidence strongly suggesting that a multigene family of
novel secreted proteins, mouse Cristin/R-spondin proteins, may work
at the receptor level to activate downstream -catenin-dependent gene
activation and may function as a class of ligands unrelated to Wnt pro-
teins.Moreover, Cristin/R-spondin proteins exhibited intriguing syner-
gistic activity on Wnt ligands, possibly through direct physical interac-
tion. Xenopus R-spondin2 and human R-spondin1 protein activity on
canonicalWnt signaling was demonstrated recently (14, 15), consistent
with our findings. These results suggest that the function of Cristin/R-
spondin family proteins is conserved in vertebrates.
MATERIALS ANDMETHODS
Molecular Biology—Mouse expressed sequence tag cDNA clones
encoding full-length Cristin/R-spondin proteins were obtained from
the I.M.A.G.E. Consortium. The coding regions of allCristin/R-spondin
genes and the deletion mutants of Cristin1/R-spondin3 were PCR-am-
plified and cloned into the pcDNA3 plasmid carrying a C-terminal
hemagglutinin (HA) tag (pcDNA3-HA) or Myc/His epitope tags
(pcDNA3.1-Myc/His). The coding sequence of mouseWnt1 was PCR-
amplified and cloned into pcDNA3-HA and the CS2-MT vectors to
create HA- and Myc-tagged constructs, respectively. DNA sequence
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encoding a cysteine-rich domain (CRD) of mouse Fzd8 was excised
from the Fzd8CRD-IgG plasmid (16) and cloned into pcDNA3-HA to
create a C-terminally HA-tagged Fzd8CRD construct (Fzd8CRD-HA).
Cell Culture, DNA Transfection, and Luciferase Assay—Human
embryonic kidney 293T cells and mouse L-cells were routinely main-
tained in Dulbecco’s modified Eagle’s medium containing 10% fetal
bovine serum in 5% CO2 at 37 °C. P19 cells were maintained in -min-
imal essential medium supplemented with 7.5% calf serum and 2.5%
fetal bovine serum. 293T cells were transfected using FuGENE6 reagent
(Roche Applied Science) according to the manufacturer’s protocol. For
luciferase assay, 3 104 cells were seeded in each well of 24-well plates.
The TOPflash or FOPflash reporter (20 ng) and a Renilla luciferase-
thymidine kinase construct (10 ng) were used along with various
amounts of expression plasmids as indicated in the figure legends. Both
luciferase activities were measured using a Dual-Luciferase assay kit
(Promega) according to the manufacturer’s protocol.
Preparation of ConditionedMedium (CM) and Isolation of Cristin/R-
spondin Proteins—Wnt3a CM was prepared from the mouse Wnt3a
L-cell line (obtained from American Type Culture Collection) as
described previously (17). CM containing Cristin/R-spondin proteins
was obtained from 293T cells transiently transfected with Cristin/R-
spondin expression plasmids. For biochemical assay, serum-free Dul-
becco’s modified Eagle’s medium/nutrient mixture F-12 (1:1) was used
to obtain the CM. Soluble heparin (50 g/ml) was added to the culture
medium. Dulbecco’s modified Eagle’s medium containing 10% fetal
bovine serumwas used to prepare the CM for the luciferase and -cate-
nin stabilization assays. For purification of histidine-tagged Cristin/R-
spondin proteins, total lysates of 293T cells transiently transfected with
histidine-tagged Cristin/R-spondin expression constructs were pre-
pared with lysis buffer (50 mM Tris (pH 8.0), 150 mM NaCl, and 0.1%
Nonidet P-40) containing protease inhibitor mixture V (Calbiochem).
The cell lysates were incubated with nickel-nitrilotriacetic acid-agarose
beads (Qiagen Inc.) for 2 h at 4 °C and washed with 10 mM imidazole
buffer three times. The Cristin/R-spondin proteins were eluted with
buffer containing 250 mM imidazole. The HA-tagged mouse Fzd8 CRD
and human IgG fusions of the mouse Fzd8 CRD and the human LRP6
extracellular domain (LRP6N) were prepared as serum-free CM for-
mats from transiently transfected 293T cells as described previously
(18).
Heparin Binding and Cristin/R-spondin Binding Assay—Total cell
lysates of 293T cells transfected with Cristin-HA constructs were pre-
pared using lysis buffer containing protease inhibitors and incubated
overnight at 4 °C with heparin-Sepharose beads (Sigma). The beads
were washed with lysis buffer three times at room temperature, and the
Cristin/R-spondin proteinswere elutedwith bufferswith differentNaCl
concentrations. The presence of Cristin/R-spondin proteins was exam-
ined by Western blot analysis.
CM containing IgG, Fzd8CRD-IgG, and LRP6N-IgG were first incu-
bated with protein A-Sepharose beads to conjugate IgG fusion proteins
to the beads. Histidine-tagged Cristin/R-spondin proteins were incu-
bated overnight at 4 °C with the beads. After three washings with 0.3 M
NaCl/phosphate buffer, the associated Cristin/R-spondin proteins were
analyzed byWestern blot analysis using anti-His, anti-HA, or anti-Myc
primary antibody. The filters were reprobed with anti-human IgG
antibody.
RNA Isolation and Reverse Transcription (RT)-PCR Analysis—Total
RNA was isolated from cultured cells and Xenopus animal cap explants
using TRIzol reagent (Invitrogen) according to the manufacturer’s pro-
tocol and digested with RNase-free DNase I to remove genomic DNA
contamination. The first-strand cDNA was synthesized with Super-
Script II (Invitrogen), and one-tenth of the cDNA was used for each
PCR. The sequences of the PCR primers were as follows: mouse glycer-
aldehyde-3-phosphate dehydrogenase (GADPH), 5-GTGGCAAAGT-
GGAGATTGTTGCC-3 (sense) and 5-GATGATGACCCGTTTG-
GCTCC-3 (antisense); mouse Cristin1/R-spondin3, 5-GTACACTG-
TGAGGCCAGTGAA-3 (sense) and 5-ATGGCTAGAACACCTGT-
CCTG-3 (antisense); mouse BrachyuryT, 5-TGCTGCCTGTGAGT-
CATAC-3 (sense) and 5-ACAAGAGGCTGTAGAACATG-3 (anti-
sense); mouse Cdx1, 5-GAACCAAGGACAAGTACCGTG-3 (sense)
and 5-GGTAGAAACTCCTCCTTGACG-3 (antisense); Xenopus
Siamois, 5-AAGGAACCCCACCAGGATAA-3 (sense) and 5-TAC-
TGGTGGCTGGAGAAATA-3 (antisense); Xenopus Xnr3, 5-TCCA-
CTTGTGCAGTTCCACAG-3 (sense) and 5-ATCTCTTCATGGT-
GCCTCAGG-3 (antisense); and Xenopus Xmax2, 5-GTGGAAAGC-
GACGAAGACTC-3 (sense) and 5-CCGAGCTCGAGTAGTTGGA-
C-3 (antisense).
Western Blot Analysis, Immunoprecipitation, and Immunofluores-
cence Staining—For Western blotting, anti-HA (clone 12CA5), anti-
Myc (clone 9E10), anti-His (Rockland Immunochemicals, Inc.), and
anti-human IgG (Jackson ImmunoResearch Laboratories, Inc.) anti-
bodies were used at 1:2000, 1:5000, 1:3000, and 1:4000 dilutions, respec-
tively. Anti--catenin (Pharmingen) and anti--actin (Sigma) antibod-
ieswere used at 1:500 and 1:5000 dilutions, respectively. The presence of
target proteins was detected by the chemiluminescencemethod (Amer-
sham Biosciences). For immunoprecipitation, protein A-Sepharose and
anti-HA or anti-Myc antibody conjugated to agarose (Sigma) or Sepha-
rose (Santa Cruz Biotechnology, Inc.) beads were used to purify the
protein complex. Subcellular localization of Cristin/R-spondin proteins
in 293T cells was determined by immunofluorescence staining using
mouse anti-HA primary antibody (1:1000 dilution) and Alexa 488-con-
jugated goat anti-mouse IgG secondary antibody (1:500 dilution;
Molecular Probe). Images were acquired by confocal microscopy.
Mouse Embryo Collection andWhole-mount in Situ Hybridization—
Wild-type embryos at different stages were collected from the timed
matings of ICR mice. The pMesogenin1 gene mutant embryos were
collected from the mating between the heterozygous animals, and the
genotypes of collected embryoswere determined by genomicDNAPCR
analysis with yolk sac DNA as described (19). The collected embryos
were immediately fixed in freshly prepared 4% paraformaldehyde/phos-
phate-buffered saline solution overnight at 4 °C and kept in 100%meth-
anol at 20 °C until used. Digoxigenin-labeled antisense Cristin1/R-
spondin3 RNA probes were synthesized in vitro from a linearized DNA
template utilizing appropriate RNA polymerases in the presence of
digoxigenin-labeled CTP. Whole-mount in situ hybridization was per-
formed as described previously (19). Stained embryos were photo-
graphed with a Zeiss AxioCam digital camera.
Xenopus Embryos and Animal Cap Explants—Xenopus embryos
were prepared by in vitro fertilization of oocytes collected from hor-
monally induced females by a standard protocol. Capped RNAwas syn-
thesized using an Ambion Message Machine kit according to the rec-
ommended protocol. Various amounts of RNA were injected into the
animal pole of two-cell stage embryos. Animal caps were explanted at
the blastula stage and cultured in 1 modified Bart’s saline until the
companion embryos reached the gastrulation stage.
RESULTS
Multigene Family of Novel Secreted Mouse Cristin/R-spondin
Proteins—Wepreviously demonstrated thatmousemutants lacking the
pMesogenin1 gene, which encodes a presomitic mesoderm-specific
basic helix-loop-helix transcription factor (20), display severe defects in
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FIGURE 1. Cristin/R-spondinmultigene family proteins are novel secreted proteins. A and B, mouse (m) Cristin1/R-spondin3 RNA expression in the tail buds of pMesogenin1-null
mutant embryoswas analyzed by both RT-PCR andwhole-mount in situhybridization, respectively. For total RNA isolation, the trunk regions below the hind limb levels of normal (,
wild-type and heterozygous embryos combined) and homozygous null mutant (/) embryos at embryonic day 9.5 (E9.5) were dissected in ice-cold phosphate-buffered saline.
More than40 individualswere combined to isolateRNA. Bothheterozygous (/) andhomozygous (/)pMesogenin1mutant embryonicday9.5 embryoswere collectedandused
for whole-mount in situ hybridization after genotyping of yolk sac genomic DNA. GAPDH, glyceraldehyde-3-phosphate dehydrogenase. C, shown is a comparison of mouse
Cristin/R-spondin family protein sequences. The predicted protein sequences were aligned using the ClustalW program of the Lasergene package (DNAStar, Inc., Madison, WI).
Identical amino acids are shown in black boxes. Hyphens indicate a sequence gap. The GenBankTM accession numbers for mouse R-spondin proteins are as follows: mouse Cristin3/
R-spondin1, NP_619624; mouse Cristin2/R-spondin2, NP_766403; mouse Cristin1/R-spondin3, AY864332; and mouse Cristin4/R-spondin4, XP_130619. D, shown is a phylogenetic
analysis of vertebrate R-spondin family proteins. The discovery of human and Xenopus R-spondins was reportedwhile thismanuscript was in preparation. The GenBankTM accession
numbers as follows: human R-spondin1, NP_775911; human R-spondin2, NP_116173; human R-spondin3, AAQ88533; human R-spondin4, XP_297816; Xenopus R-spondin2,
AY753198; and Xenopus R-spondin3, AY753199.Mm,Musmuscularis; Hs, Homo sapiens; Xl, Xenopus laevis. Xt, Xenopus tropicalis. E, the syntenic relationship between human (H) and
mouse (M)R-spondingene loci is shown. Thepredictedprotein sequencesof humanR-spondin1donot contain anynotable signal sequences. It is unclearwhether this particularDNA
sequence represents an alternatively spliced form or an artifact of cDNA cloning. Therefore, the number of exons of the human R-spondin1 gene is provisional. Chr., chromosome.
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posterior paraxial mesoderm development (19). In an attempt to under-
stand the molecular mechanisms by which pMesogenin1 regulates
paraxial mesoderm development, potential target genes for pMesoge-
nin1 were screened by analyzing gene expression profiles in the pre-
somitic mesoderm of pMesogenin1-null and wild-type embryos. One
gene whose RNA expression was increased by4-fold in the pMesoge-
nin1-null mutant samples encoded a novel secreted protein (Fig. 1A).
Based on the protein structure derived from the predicted peptide
sequences, we named this gene Cristin1 (for cysteine-rich and single
thrombospondin domain-containing protein-1) (Fig. 1C). Whole-
mount in situ hybridization analysis showed prominent RNA expres-
sion of Cristin1 in the tail buds of wild-type mouse embryos (Fig. 1B).
Cristin1 expression within the tail buds of homozygous pMesogenin1-
null mutants was significantly expanded, increased, and tightly associ-
ated with the tail bud defects, consistent with RT-PCR data. Thus, aber-
rant Cristin1 expression may be related to the pMesogenin1-null
phenotype.Cristin1 expressionwas also detected in the primitive streak,
dorsal neural tube, forebrain, and migrating neural crests of mouse
embryos (Fig. 1B). In searching sequence data bases, we identified three
genes homologous toCristin1 in themouse genome (designated asCris-
tin2, Cristin3, and Cristin4) (Fig. 1C). We also identified four homolo-
gous genes in the human genome as well as expressed sequence tag
clones with high sequence homology among other vertebrates, includ-
ing chicken, Xenopus, and zebrafish. Phylogenetic analysis of predicted
protein sequences, syntenic relationships of gene loci in human and
mouse chromosomes, and comparisons of genomic structures deter-
mined the orthologous relationships among the human and mouse
genes (Fig. 1, D and E). Interestingly, searches of the Drosophila and
C. elegans genome data bases failed to identify Cristin homologs. Thus,
Cristin genes may be unique to vertebrates, although functional
homologs may exist in invertebrate species. Recently, the isolation of
mouse R-spondin, which is identical to mouse Cristin3, and two Xeno-
FIGURE2.Cristin/R-spondinsare secretedproteins.A,mouseCristin/R-spondins (Rspo) are localized in theendoplasmic reticulumandGolgi apparatus in 293T cells. 293T cellswere
cotransfected with Cristin/R-spondin-HA expression plasmids and pDsRed2-ER (Clontech). The majority of Cristin/R-spondin proteins co-localized with the DsRed proteins residing
in the endoplasmic reticulum. The white arrow indicates Cristin/R-spondin expression in the Golgi apparatus. B, mouse Cristin/R-spondins are secreted proteins. 293T cells were
transfected with expression plasmids encoding HA-tagged Cristin/R-spondin proteins. Total cell lysates (TCL) and serum-free CM were analyzed by Western blotting using anti-HA
antibody.
FIGURE3.Cristin/R-spondins areheparin-bindingproteins.A, total cell lysates (TCL) containingCristin/R-spondin (Rspo) proteinswere incubatedwithheparin-agarosebeads, and
the bound proteins were eluted with buffers containing different concentrations of NaCl. The presence of Cristin/R-spondin proteins was analyzed using 0.1 volume of each eluted
fraction byWestern blot analysis using anti-HA antibody. B, shown is a schematic diagram of Cristin1/R-spondin3-HA deletion constructs. BR, basic amino acid-rich domain; CR, CRD;
SS, single sequence; TB, TSR plus BR. C, total cell lysates containing various Cristin1/R-spondin3 deletion constructs were incubated with heparin-agarose beads, and the bound
proteins were eluted with 1.5 M NaCl buffer. 0.1 volume of eluted protein was analyzed by Western blotting as described for A. To monitor protein expression levels, the Cristin1/R-
spondin3 protein expression level was measured in total cell lysates.
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pus homologs of the mouse R-spondin genes was reported (14, 21).
Thus, for consistency in nomenclature, we renamed theCristin genes to
R-spondin as indicated in Fig. 1D.
Comparisons of the predicted mouse R-spondin amino acid
sequences revealed significant homologies (Fig. 1C). First, all R-spondin
proteins contain anN-terminal 20–25-amino acid hydrophobic region,
which likely serves as a signal sequence for secretion. Three additional
conserved protein domains are evident: (i) a CRDwith homology to the
CRDs of furin and the insulin-like growth factor receptor, (ii) a throm-
bospondin type I repeat (TSR) (22), and (iii) a C-terminal basic amino
acid-rich domain (Fig. 1C).
The presence of a putative signal sequence and the lack of a notable
transmembrane domain suggest that R-spondins may be secreted pro-
teins. To test this possibility, we transfected expression plasmids encod-
ing HA-tagged R-spondins into human embryonic kidney 293T cells
and examined the subcellular localization of R-spondins by immunoflu-
orescence staining. R-spondin proteins were detected mainly in the
endoplasmic reticulum and the Golgi apparatus (Fig. 2A), indicating
that R-spondin proteins are in the secretory pathway. In similarly trans-
fected cells, the expression of R-spondin proteins and their secretion
into the CM were monitored by Western blot analysis. The majority of
the R-spondin proteins were associated with total cell lysates and were
barely detected, if at all, in theCM(Fig. 2B). Interestingly, the addition of
soluble heparin to the medium in culture significantly enhanced the
presence of R-spondins in the CM and confirmed their nature as
secreted proteins (Fig. 2B). The addition of sodium chlorate, an inhibi-
tor of sulfation, increased the level of R-spondin proteins in the CM.3
These results suggest that secreted R-spondins may be associated, in
part, with the heparan sulfate proteoglycans (HSPGs) of the plasma
membrane and extracellular matrix.
R-spondin Binds to Heparin with High Affinity—We next examined
whether R-spondin can bind to heparin.We prepared lysates from293T
cells transfected with R-spondin-HA expression plasmids. The cell
lysates were incubated with heparin-Sepharose beads, and the bound
proteins were eluted with a series of buffers with different salt concen-
trations. All R-spondins tested efficiently bound to the heparin-Sepha-
rose beads and were eluted from the heparin beads between 0.8 and 1.2
MNaCl (Fig. 3A). Thus, all R-spondins bind to heparin with high affinity
comparable with fibroblast growth factors (23).
To determine which domains within R-spondin3 are required for
heparin binding, we generated a set of R-spondin3 constructs contain-
3 J.-S. Nam, T. J. Turcotte, and J. K. Yoon, unpublished data.
FIGURE 4. Cristin/R-spondin proteins activate
canonical Wnt/-catenin signaling. A, mouse
Cristin1/R-spondin3 (Rspo3) induced -catenin-
dependent gene activation in a dose-dependent
manner. 20 ng of TOPflash or FOPflash reporter
plasmid was cotransfected with the indicated
amounts of Cristin1/R-spondin3 expression plas-
mid into 293T cells grown in 24-well plates. 10 ng
ofRenilla luciferasedrivenby the thymidine kinase
genepromoterwas includedas a transfection con-
trol. B, Cristin/R-spondin functioned at the ligand/
receptor level. 293T cells were transfected with
mouse Fzd8 (25 ng) and human LRP6 (10 ng)
expression plasmids and stimulated with CM con-
taining Cristin1/R-spondin3 for 24 h. The TOPflash
reporter activities were measured. CMV, cytomeg-
alovirus.C, Dkk1 andKremen1 reversed the activa-
tion of the TOPflash reporter that was induced by
both Cristin1/R-spondin3 and LRP6. 293T cells in
24-well plates were transfected with various com-
binations of Cristin1/R-spondin3 (25 ng), LRP6 (10
ng), Dkk1 (10 ng), and Kremen1 (10 ng) expression
plasmids with the TOPflash reporter (20 ng). D, no
synergy between Cristin1/R-spondin3 and intra-
cellular components of theWnt signalingpathway
in the activation of the TOPflash reporter was
observed. Expression plasmids encoding human
-catenin(S33A) (-cat(S33A); 80 ng), human TCF1
(10 ng), and human Dvl1 (50 ng) were cotrans-
fected into 293T cells for the TOPflash reporter
assay as indicated. E, Cristin1/R-spondin3 failed to
potentiate the TOPflash reporter activation
induced in 293T cells by treatment with LiCl, an
inhibitor of glycogen synthase kinase-3. 293T
cellswere transfectedwith theR-spondin1 expres-
sion plasmid and the TOPflash reporter. At 24 h
after transfection, the cells were treated with
either LiCl (40 mM) or NaCl (40 mM) for 8 h.
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ing various deletions of the identified domains (Fig. 3B). Total lysates of
293T cells transfected with these constructs were prepared, and the
heparin binding of each protein construct was determined. It appears
that both the basic amino acid-rich and TSR domains contain the
majority of heparin binding capability, as deletion of both domains sig-
nificantly decreased R-spondin3 binding to heparin (Fig. 3C). In con-
trast, R-spondin3 with a CRD deletion showed efficient binding to hep-
arin comparable with wild-type R-spondin3, indicating that the CRD
may not be necessary for heparin binding. We concluded that
R-spondin3 is a heparin-binding protein and that both the TSR and
basic amino acid-rich domains are necessary for binding to heparin.
R-spondin Activates Canonical Wnt/-Catenin Signaling—Two
observations led us to evaluate the possible involvement of R-spondin in
Wnt signaling. First, embryonic expression of R-spondin genes highly
overlaps with known wnt gene expression domains (24). Second, CCN
(CYR61/connective tissue growth factor/NOV) family proteins, which
contain domains structurally similar to those of R-spondins such as the
cysteine-rich and TSR domains (25), were recently demonstrated to
either antagonize or agonize Wnt signaling in a context-dependent
manner (26, 27). The steady-state level of -catenin protein and the
activity of reporter constructs such as the TOPflash reporter carrying
TCF1-binding sites in their upstream regulatory regions were exten-
sively used to analyze canonical Wnt signaling. In 293T cells, overex-
pression of R-spondin3 strongly induced TOPflash reporter activity in a
dose-dependent manner (Fig. 4A). Activation was dependent on the
TCF1-binding site because a reporter carrying nonfunctional TCF1-
binding sites (FOPflash) was not activated by R-spondin3. In addition,
other mouse R-spondin family members and Xenopus R-spondin2
showed similar activities (14).3 Interestingly, CM collected from the
culture of 293T cells transfected with R-spondins effectively induced
TOPflash reporter activity, suggesting that R-spondin may act in the
extracellular environment (Fig. 4B).
To determine the target position for R-spondin activity in the Wnt
signaling axis, we examined reporter activity under conditions of
R-spondin3 coexpression with various Wnt signaling components.
R-spondin3 activity was synergistically potentiated by the LRP6 recep-
tor (Fig. 4B). However, unlike Wnt ligands, R-spondin3 failed to show
any significant synergy with Fzd8 (Fig. 4B). Fzd8 failed to further
enhance the reporter activity co-induced by R-spondin3 and LRP6 (Fig.
4B). Therefore, Fzd8 does not appear to actively contribute to the intra-
cellular transmission of R-spondin signals. Furthermore, the reporter
activity induced by both LRP6 and R-spondin3 was sensitive to the
presence of both Dickkopf1 (Dkk1) (28) and Kremen1 (29), a condition
that presumably enhanced LRP6 receptor endocytosis and inhibited
intracellular signaling through the LRP6 receptor (Fig. 4C) (29). How-
ever, Dkk1 or Kremen1 alone marginally affected or had no effect on
reporter activity induced by R-spondin3 and LRP6.
In contrast, R-spondin3 failed to show any synergistic activation of
the reporter when coexpressed with other intracellular components of
Wnt signaling, including Dvl1 or-catenin/TCF1 (Fig. 4D). In addition,
when cells were treated with LiCl, which mimics Wnt activation by
inhibiting glycogen synthase kinase-3, no synergistic activation with
R-spondin3 of reporter activity was observed (Fig. 4E).
R-spondin Stabilizes Endogenous -Catenin and Induces the Known
Canonical Wnt/-Catenin Target Genes—We examined R-spondin
activity on stabilization of -catenin, a landmark intracellular event
upon activation of canonical Wnt signaling. R-spondin1 and
R-spondin3 CM effectively increased steady-state -catenin levels in
293T cells compared with Wnt3a CM (Fig. 5A), consistent with the
reporter assay results. This result clearly shows that degradation of cyto-
plasmic -catenin was prevented by R-spondins and that accumulated
-cateninmay lead to the activation of reporter activity as shown in Fig.
4A. Both Xenopus R-spondin2 and human R-spondin1 also induce the
stabilization of -catenin (14, 15), consistent with our results.
We further investigated whether R-spondin can induce the expres-
sion of genes known as canonical Wnt signaling targets. Mouse embry-
onic carcinoma P19 cells were stimulated with Wnt3a or R-spondin3
CM for 2 and 3 days, respectively, and expression of BrachyuryT and
Cdx1, two known Wnt3a target genes, was examined by semiquantita-
tive RT-PCR analysis. Robust induction of both genes was observed in
cells incubated with R-spondin3 andWnt3a CM, respectively (Fig. 5B).
Because both genes are expressed in the tail bud regions of mouse
embryos (30, 31), where R-spondin3 is also expressed, it is likely that
both BrachyuryT and Cdx1 are direct downstream targets of
R-spondin3 signaling.
Axis duplication assay inXenopus embryos is a signature assay to test
Wnt/-catenin activation in vivo. We next examined whether ectopic
R-spondin expression in Xenopus embryos induces axis duplication.
Injection of up to 5 ng of R-spondin1 and R-spondin3 RNAs into one of
the ventral blastomeres in four-cell stage embryos did not induce any
significant axis duplication phenotype, whereas similarly injected wnt1
RNA in a picogram quantity produced a clear duplication of axis (data
not shown). Our results are consistent with those recently reported for
the Xenopus R-spondin2 gene (14). The majority of embryos injected
with a high concentration of R-spondin3 RNA displayed severe gastru-
lation failure. Additionally, we occasionally observed tail duplication in
a small number of theR-spondin3RNA-injected embryos. Interestingly,
unlike whole embryo injection, transcription of two knownWnt target
genes, Siamois andXnr3, was significantly enhanced in Xenopus animal
cap explants injected with mouse R-spondin3 RNA compared with
uninjected and control enhanced green fluorescent protein RNA-in-
jected cap explants (Fig. 5C).We concluded that the R-spondin family of
FIGURE 5. A, stabilization of -catenin proteins by R-spondins. 293T cells were treated
with CM containing R-spondin1 (Rspo1), R-spondin3 (Rspo3), or Wnt3a for 12 h. The
steady-state level of endogenous -catenin protein was analyzed by Western blotting.
-Actin expression was measured by Western blotting to provide a control for total
sample quantity. B, induction of Wnt3a target genes by Cristin1/R-spondin3 in embry-
onic carcinoma P19 cells. Monolayer cultured P19 cells were stimulated with Cristin1/R-
spondin3 CM (1:2) or Wnt3a CM (1:10) for 1 (D1) and 2 (D2) days, respectively. RNA
expression of the BrachyuryT and Cdx1 genes was analyzed by semiquantitative RT-PCR.
Glyceraldehyde-3-phosphatedehydrogenase (GAPDH) expressionwas alsomeasured to
ensure the quality and quantity of cDNA samples. C, induction of Wnt target genes in
Xenopus animal cap explants injected with mouse R-spondin1 RNA. Injection of mouse
(m)Cristin1/R-spondin3 RNA (5 ng) ormousewnt1 RNA (10 pg) inducedboth Siamois and
Xnr3 RNA expression effectively. Co-injection of Cristin1/R-spondin3 (1 ng) andwnt1 (0.5
pg) RNAs at suboptimal concentrations synergistically activated target gene expression.
To ensure the quantity and quality of cDNA samples, elongation factor-1 (EF1) gene
expression was measured. EGFP, enhanced green fluorescent protein.
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proteins possesses signaling activities that induce -catenin-dependent
gene activation.
Binding of R-spondin to the Extracellular Domains of Fzd8 and LRP6
Receptors—To biochemically characterize R-spondin activity in the
FzdLRP receptor complexes, we examined whether R-spondin3 binds
to the extracellular domain of Fzd8, LRP6, or both. First, we utilized a
cotransfection/co-immunoprecipitation format. Expression plasmids
encoding mouse R-spondin3 tagged with the HA epitope and human
IgG fusions of the CRD of mouse Fzd8 (Fzd8CRD-IgG) (16) and the
extracellular domain of human LRP6 (LRP6N-IgG) (32) were cotrans-
fected into 293T cells. Cell lysates were subjected to immunoprecipita-
tion followed by Western blot analysis. The R-spondin3 protein was
effectively co-immunoprecipitated with Fzd8CRD-IgG and LRP6N-
IgG, but not with IgG (Fig. 6A). Although much less concentrated than
Fzd8CRD-IgG, the LRP6N-IgG protein co-immunoprecipitated a com-
parable amount of R-spondin3. Thus, R-spondin3may bind to the LRP6
ectodomain at a higher affinity than to the CRD of Fzd8 in vivo. In
contrast, more R-spondin3 molecules may bind to the LRP6 ectodo-
main than to the CRD of Fzd8.
We next examined these interactions under cell-free liquid-phase
conditions. We isolated histidine-tagged R-spondin1 and R-spondin3
proteins from total lysates of 293T cells transiently transfected with
R-spondin expression plasmids. Fzd8CRD-IgG and LRP6N-IgG fusion
proteinswere prepared in aCM format as described (32).We found that
both R-spondin1 and R-spondin3 were specifically coprecipitated with
Fzd8CRD-IgG and LRP6N-IgG, but not with IgG (Fig. 6B). Similar
to the cotransfection/co-immunoprecipitation results, R-spondin
proteins appeared to bind to LRP6N-IgG more efficiently than to
Fzd8CRD-IgG, as similar amounts of R-spondins were co-immunopre-
cipitated with a reduced amount of LRP6N-IgG.
Because the Wnt1 ligand has been shown to form a ternary complex
with Fzd8 and LRP6 under in vitro binding conditions (32), we next
examined whether R-spondin can form a similar ternary complex with
both receptors. LRP6N-IgG andFzd8CRD-HA failed to forma complex
(Fig. 6C), consistent with the previously reported results (32).When the
R-spondin1-Myc/His protein was incubated with both LRP6N-IgG and
Fzd8 CRD-HA, we could not detect any Fzd8 CRD-HA protein in the
immunoprecipitated LRP6N-IgG construct, whereas R-spondin1-Myc/
His was present in the construct (Fig. 6C). This result suggests that,
unlike Wnt1 ligands, the R-spondin, LRP6, and Fzd8 proteins do not
form a ternary complex. Interestingly, the presence of Fzd8 CRD-HA in
the binding reaction significantly reduced the binding of R-spondin1 to
LRP6N-IgG (Fig. 6C), indicating that Fzd8 CRD-HAmay compete with
LPR6-IgG for binding to R-spondin1. The same or overlapping domain
of the R-spondin1 protein may be engaged in binding to both LRP6 and
Fzd8 receptors.
To further investigatewhich domain of R-spondin is involved in these
interactions, we cotransfected R-spondin3 deletion mutants with
Fzd8CRD-IgG or LRP6N-IgG and analyzed their interactions. We
determined that the CRD of R-spondin3 was essential for the interac-
tion with both Fzd8 and LRP6 receptors (Fig. 7, A and B). The
R-spondin3 construct lacking theCRD failed to signal through the LRP6
FIGURE 6. A, in vivo interaction of Cristin1/R-spondin3 (Rspo3) withmouse Fzd8 and human LRP6. Expression plasmids encoding themouse Fzd8 CRD (Fzd8CRD-IgG) and the human
LRP6 ectodomain (LRP6N-IgG) as human IgG Fc fusion proteins and control IgG were cotransfected with the Cristin1/R-spondin3-HA plasmid into 293T cells. Total cell lysates (TCL)
were prepared and subjected to immunoprecipitation (IP) using protein A-Sepharose. Immunoprecipitated proteins were further analyzed by Western blot (WB) analysis using
anti-HAor anti-human IgGantibody (Ab). To confirm thepresenceof Cristin/R-spondinprotein, total cell lysateswere also analyzedby anti-HAWesternblotting. Theasterisk indicates
the nonspecific protein band detected by anti-HA antibody. B, in vitro interaction of Cristin/R-spondin with the Fzd8 or LRP6 receptor. R-spondin1-Myc/His and R-spondin3-His
proteinswere added after IgG, Fzd8CRD-IgG, or LRP6N-IgG in CMwas prebound to protein A-Sepharose.C, No Ternary complex formationwas detected in R-spondin1-Myc/His, Fzd8
CRD-HA, and LRP6N-IgG. Input represents one-tenth of the proteins used in the binding reactions.
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receptor in the reporter assay (Fig. 7C), consistent with the co-immu-
noprecipitation results. Interestingly, R-spondin3 lacking both TSR and
basic amino acid-rich domains also showed reduced activation. How-
ever, this result appears to reflect the lower level of expression, not the
activity, of this construct.
R-spondin PositivelyModulatesWnt Ligand Activity—We unexpect-
edly observed that cotransfection of canonical Wnt proteins, including
Wnt1 and Wnt3a, and R-spondin3 also induced TOPflash reporter
activity at a significantly higher level than either Wnt or R-spondin3
individually (Fig. 8A). R-spondin1, R-spondin2, andR-spondin4 showed
similar synergistic activities with Wnt proteins on the induction of
reporter activity.3 Both the CM stimulation and DNA-mediated trans-
fection formats generated similar synergistic activation by R-spondin3
and Wnt3a (Fig. 8A), indicating that synergistic activation of Wnt sig-
naling by R-spondin occurs in the extracellular environment.We exam-
ined the steady-state level of -catenin protein in mouse L-cells after
exposure to Wnt3a CM, R-spondin CM, or a mixture of Wnt3a and
R-spondin CM. Stimulation of cells with both R-spondin and Wnt3a
synergistically enhanced -catenin stability (Fig. 8B), consistent with
reporter assay results. Similar synergistic activation of signaling was
observed in the activation of Siamois and Xnr3 gene transcription in
Xenopus animal cap explants (Fig. 5C).
To investigate the biochemical nature of this synergistic activity
between R-spondin andWnt proteins, we examined whetherWnt1 and
R-spondin proteins physically interact with each other in cultured cells.
In the lysates of 293T cells cotransfected with Wnt1-Myc and
R-spondin-HA expression plasmids, Wnt proteins were efficiently co-
immunoprecipitated with R-spondin1, R-spondin2, and R-spondin3
proteins (Fig. 8C). R-spondin2 seemed to be co-immunoprecipitated
with Wnt1 less effectively compared with R-spondin1 and R-spondin3.
Thus, R-spondins appear to be physically associated withWnt proteins,
possibly through direct interaction.
To further determine which domain of R-spondin3 interacts with the
Wnt1 protein, a series of R-spondin3 deletion constructs were tested for
their ability to bind to the Wnt1 protein by a cotransfection/co-immu-
noprecipitation format in 293T cells. The R-spondin3 construct lacking
the CRD did not co-immunoprecipitate with the Wnt1-Myc protein
(Fig. 8D), indicating that the CRD of R-spondin3 is required for binding
to Wnt1. Consistent with this result, cotransfection of Wnt1 and
R-spondin3 lacking the CRD did not cause the synergistic activation of
the TOPflash reporter, whereas other R-spondin3 constructs synergis-
tically activated the reporter in the presence of Wnt1 (Fig. 8E). We
concluded that theCRDof R-spondin3 is necessary for its positivemod-
ulatory activity on the Wnt1 protein.
DISCUSSION
R-spondins as Novel Ligands for Canonical Wnt Signaling—The
canonical Wnt signaling pathway consists of Wnt ligands and a
receptor complex consisting of Fzd family and LRP5/6 receptors at
the plasma membrane (6). Several recent studies have expanded our
knowledge of the repertoire of ligands and receptors involved in
Wnt/-catenin signaling. First, Norrin, a non-Wnt related protein,
was identified as a specific ligand for the Fzd4LRP6 receptor com-
plex (8). Second, the RYK receptor and its invertebrate homologs
Derailed (Drosophila) and LIN-18 (C. elegans) were demonstrated to
be receptors for Wnt ligands (9–11). In both cases, the ligand bind-
ing to the receptors induced effective -catenin-dependent gene
activation in signal recipient cells.
Our data clearly demonstrate that R-spondins are novel ligands for
the Fzd8 and LRP6 receptors and induce -catenin/TCF-dependent
FIGURE 7. CRD of Cristin1/R-spondin3 is a pri-
mary region for interactingwith the Fzd8LRP6
receptor complex. A, 293T cells were cotrans-
fected with the expression plasmid encoding
LRP6N-IgG and R-spondin3 (Rspo3) derivatives
carrying various deletions. Total cell lysates (TCL)
were prepared and subjected to immunoprecipi-
tation (IP) with protein A-Sepharose, followed by
Western blot (WB) analysis using anti-HA and anti-
human IgG antibodies (Ab). Total cell lysates were
also analyzed by anti-HAWestern blotting to con-
firm the presence of proteins in the cell lysates.
Theasterisk indicates thenonspecific proteinband
detected by anti-HA antibody. BR, basic amino
acid-rich region; CR, CRD; TB, TSR plus BR. B, 293T
cells were cotransfected with the expression plas-
mid encoding Fzd8CRD-IgG and Cristin1/R-
spondin3 derivatives carrying various deletions.
Immunoprecipitation and Western blot analyses
were performed as describe for A. C, the CRD of
Cristin1/R-spondin3mediated a synergistic activa-
tion of -catenin-dependent gene expression by
LRP6 and Cristin1/R-spondin3. 293T cells were
cotransfected with the TOPflash reporter, the
human (h) LRP6 expression plasmid, and various
Cristin1/R-spondin3 deletion constructs and
assayed for reporter luciferase activity. The expres-
sion level of the Rspo3TB-HA construct was
lower than that of other deletion constructs in
most of the tested cases. CMV, cytomegalovirus.
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gene activation. Recently, the discovery of Xenopus R-spondin2 and
R-spondin3 genes was reported (14). Xenopus R-spondin2 and human
R-spondin1 exhibit a positive signaling activity on canonical Wnt sig-
naling (14, 15), consistentwith our results.However, both studies lacked
any evidence showing the interactions between R-spondin and the Fzd
and LRP5/6 receptors. In their report on Xenopus R-spondin2, Kazan-
skaya et al. (14) suggested that their attempt to determine binding
between R-spondin and the Fzd or LRP6 receptor failed. However, we
FIGURE 8.Cristin/R-spondinproteins function as apositivemodulator ofWnt ligands.A, Cristin1/R-spondin3 (Rspo3) CMandWnt3a CM synergistically induce TOPflash reporter
activity. 293T cellswere transfectedwith the TOPflash reporter and stimulatedwithWnt3aCM (1:2), Cristin1/R-spondin3CM (1:2), or both for 8 h. Control CMwas used for diluting the
CM or as a background. In a parallel experiment, expression plasmids encoding Wnt3a and Cristin1/R-spondin3 were cotransfected into 293T cells and tested for synergism. B,
synergistic increase in the steady-state level of-catenin protein inmouse L-cells stimulatedwith various concentrations ofWnt3a (1:2–50), Cristin1/R-spondin3 CM (1:2), or both for
12 h. The -catenin protein level was determined by Western blot analysis. The -actin level was also measured to confirm an equivalent amount of sample loading. C, Wnt1 and
Cristin/R-spondin proteins are associated with each other in 293T cells. 293T cells were cotransfected with Wnt1-Myc and different Cristin/R-spondin-HA expression plasmids. As a
negative control, the enhanced green fluorescent protein (EGFP)-HA expression plasmid was cotransfected with the Wnt1-Myc plasmid. Total cell lysates (TCL) were prepared and
subjected to immunoprecipitation (IP) using anti-HA antibody (Ab)-agarose beads. The immune complexes were analyzed by Western blotting (WB) using anti-Myc antibodies. To
determine protein expression, total cell lysateswere also analyzedbyWestern blotting using anti-Myc and anti-HA antibodies.D, the CRDof R-spondin3 is required forWnt1 binding.
R-spondin1 deletion constructs tagged with the HA epitope were cotransfected with the Wnt1-Myc plasmid into 293T cells. Anti-Myc antibody-agarose beads were used to
immunoprecipitate theWnt1-Myc protein from cell lysates. Anti-HA and anti-Myc antibodies were used to detect R-spondin1 derivatives andWnt1 protein, respectively, within the
immune complex by Western blot analysis. Expression of the R-spondin1 derivatives was also determined by Western blot analysis of total cell lysates using anti-HA antibody. BR,
basic amino acid-rich domain; CR, CRD. E, the CRD of R-spondin3 is necessary for the synergistic regulation of TOPflash reporter activity induced by Wnt1. Wnt1-Myc (25 ng) and
R-spondin1-HA deletion constructs (25 ng) were cotransfected with the TOPflash reporter (20 ng) into 293T cells.
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convincingly demonstrated that R-spondin interacts with the extracel-
lular domains of the Fzd8 and LRP6 receptors both in vivo and in vitro
(Fig. 6). It is difficult to understand the reason for the different results. It
is possible that Xenopus R-spondin may have a significantly weaker
binding activity for the receptors, which made it difficult to detect the
interaction in their assay. Nonetheless, our results confirm that mouse
R-spondin is indeed a novel ligand for both Fzd and LRP receptors.
Interestingly, the Fzd8 receptor was incompetent tomediate a down-
stream signaling event leading to -catenin-dependent gene activation
despite the efficient binding to the R-spondin protein (Figs. 4B, 6, and
7B). Two explanations are possible for these puzzling data. First, an
increasing body of evidence indicates that signaling activities through
the LRP6 receptor may be dissociated from those through the Fzd
receptors (33–36). Thus, preferential R-spondin signaling through the
LRP6 receptor may be another example of dissociation of intracellular
signaling events at the receptor level. Therefore, R-spondin binding to
the LRP6 receptor may be sufficient to induce -catenin-dependent
signaling without any contribution from Fzd (Fig. 9, Model 3). Our
result from the in vitro binding assay supports this possibility. Unlike
canonical Wnt ligands that could induce ternary complex formation
with the Fzd8 and LRP6 receptors (Fig. 9, Model 1), the R-spondin1
protein failed to form a ternary complex (Fig. 6C). Because the same
CRD of R-spondin was required for binding to the Fzd and LRP6 recep-
tors (Fig. 7), it is likely that R-spondin binding to both receptors may be
competitive. Consistent with this notion, Fzd8 CRD-HA significantly
inhibited the binding of R-spondin1 to the LRP6N-IgGprotein (Fig. 6C).
Because the association of Fzd and LRP6 mediated by canonical Wnt
ligands appears to be critical for activating downstream events (18), this
result suggests that R-spondin induces -catenin-dependent gene acti-
vation by mechanisms distinct from Wnt signaling. Furthermore, it is
possible that the R-spondin and Fzd interaction may induce only non-
canonical signaling independent of -catenin (Fig. 9,Model 4).
Second, R-spondinmay preferentially bind to and transmit the signal
through other Fzd receptors alongwith the LRP6 receptor (Fig. 9,Model
2). Although it is currently unknownwhether other Fzd receptors trans-
duce R-spondin signals, this is a very plausible scenario given that the
Norrin ligand transduces the signal exclusively through the Fzd4LRP6
receptor complex (8).
Positive Modulation of Wnt Ligand Activity by R-spondin—Surpris-
ingly, we discovered that R-spondin plays a positive modulatory role in
Wnt ligand activity presumably by directly interacting withWnt ligands
(Fig. 8). It appears that the CRD of R-spondin3 is necessary for this
activity (Fig. 8, D and E). How can R-spondins modulate Wnt activity?
First, it is plausible that the WntR-spondin complex is a higher affinity
ligand than Wnt or R-spondin individually. Second, R-spondin may
stabilize the Wnt ligand/receptor interaction without increasing the
binding affinity of the Wnt ligand for the receptor. Third, Wnt may be
protected from degradation or turnover when it is associated with
R-spondin. Themolecular mechanisms underlying this activity will be a
focus of future studies.
A large number of Wnt antagonists are known. Some Wnt antago-
nists, including secreted Frizzled-related proteins (37) andWnt inhibi-
tory factor (38), likely inhibitWnt signaling activity by direct interaction
with Wnt proteins to prevent their receptor binding. In contrast, Dkk1
may not directly interact with Wnt proteins, but may regulate LRP5/6
receptor endocytosis or availability (29). Because R-spondin seems to
directly interact withWnt proteins, how R-spondin activity is regulated
by otherWnt-binding antagonists will be a focus of future investigation.
To this end, theCCN family proteins, which primarily act asWnt antag-
onists (26, 27), are of particular interest. The presence of similar protein
motifs such as TSRs and CRDs in both R-spondins and CCN proteins
(25) strongly suggests that they may belong to the ligand superfamily
and have opposing activities for modulating Wnt signaling activity.
Possible Regulatory Role of HSPGs in R-spondin and Wnt Signal-
ing—The majority of R-spondin proteins expressed in the cells appear
to reside within the endoplasmic reticulum and Golgi apparatus,
whereas a relatively small portion is secreted from cells (Fig. 2). The
secreted R-spondin seems to be associated with the plasma membrane
and extracellular matrix. We found that R-spondins are heparin-bind-
ing proteins with high affinity and that both the TSR and basic domains
of R-spondin3 are required for this binding (Fig. 3). Therefore, it is
highly likely that secreted R-spondin is associated with HSPGs on the
plasma membrane and extracellular matrix.
Heparin or HSPGs play important regulatory roles in growth factor/
cytokine signaling (39, 40). The role of HSPGs in Wnt signaling was
recently demonstrated (41–43). Two models have been proposed for a
HSPG regulatory role inWnt signaling based primarily on studies on the
Drosophila Wnt homolog Wingless (44). First, HSPGs control either
degradation or diffusion of Wingless to regulate its availability. Second,
HSPGs serve as low affinity receptors for the Wingless ligand and may
facilitate its binding to the Fzd/LRP receptors. It was demonstrated
recently that heparin binding to Wnt ligands inhibits Wnt signaling
activity in mammalian cells (41). Furthermore, Chinese hamster ovary
cell mutants for heparan sulfate biosynthesis are defective in the activa-
tion of Fzd receptor signaling (41). It would be intriguing to determine
whether HSPGs regulate R-spondin signaling activity and, if so, what
the underlying mechanisms are. In our preliminary studies, we found
that soluble heparin exhibited an inhibitory activity on R-spondin sig-
naling, similar to Wnt signaling.3
Fine Control of Canonical Wnt Signaling Activity—Our study has
provided evidence that R-spondin family proteins are novel ligands for
the Fzd8 and LRP6 receptors. Furthermore, R-spondin proteins can
induce -catenin-dependent gene activation likely through the LRP6
receptor by mechanisms different from those in canonical Wnt signal-
ing. Interestingly, under R-spondin and Wnt coexistence conditions,
the signaling activity of the WntR-spondin ligand complex is signifi-
cantly higher than that of either Wnt or R-spondin alone. Thus, com-
binatorial expression of R-spondin andWnt proteins may produce dif-
ferential signaling activities that lead to differential activation of a
battery of genes, which eventually govern the outcome of cellular pro-
cesses. Future studies will be focused on determining the molecular
mechanisms by which the differential signaling activity is regulated. In
addition, the co-presence of different secretedWnt antagonists (37) will
FIGURE 9. Proposed models for Cristin/R-spondin and Wnt signaling through the
Fzd and LRP6 receptors.Model 1 is a current view of canonical Wnt signaling. InModel
2, Cristin/R-spondin proteins generate-catenin-dependent signaling through the Fzd/
LRP6 receptors, similar to canonical Wnt signaling. In contrast, Cristin/R-spondin may
transduce its signal through the LRP6 receptor (Model 3). Cristin/R-spondin also induces
non-canonical Wnt signaling through the Fzd receptor (Model 4). Wnt and Cristin/R-
spondin ligands are indicated bywhite and gray ovals, respectively.
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further define the level of signaling activity, although whether any
knownWnt antagonists affect R-spondin activity is unknown.
Acknowledgments—We thanks Drs. Robert Friesel, Lucy Liaw, Leif Oxburgh,
Doug Spicer, and DonWojchowski for critical reading of and comments on the
manuscript and Norma Albrecht for proofreading. We are indebted to Drs.
Rudolf Grosschedl, Xi He, Jen-Chih Hsieh, Nobue Itasaki, Randall Moon,
Christof Niehrs, and Roel Nusse for reagents.
REFERENCES
1. Wodarz, A., and Nusse, R. (1998) Annu. Rev. Cell Dev. Biol. 14, 59–88
2. Polakis, P. (2000) Genes Dev. 14, 1837–1851
3. Malbon, C. C. (2004) Front. Biosci. 9, 1048–1058
4. Wang, H. Y. (2004) Front. Biosci. 9, 1043–1047
5. Moon, R. T., Bowerman, B., Boutros, M., and Perrimon, N. (2002) Science 296,
1644–1646
6. He, X., Semenov, M., Tamai, K., and Zeng, X. (2004) Development (Camb.) 131,
1663–1677
7. Kuhl, M. (2004) Front. Biosci. 9, 967–974
8. Xu, Q., Wang, Y., Dabdoub, A., Smallwood, P. M., Williams, J., Woods, C., Kelley,
M. W., Jiang, L., Tasman, W., Zhang, K., and Nathans, J. (2004) Cell 116, 883–895
9. Inoue, T., Oz, H. S., Wiland, D., Gharib, S., Deshpande, R., Hill, R. J., Katz, W. S., and
Sternberg, P. W. (2004) Cell 118, 795–806
10. Lu, W., Yamamoto, V., Ortega, B., and Baltimore, D. (2004) Cell 119, 97–108
11. Yoshikawa, S., McKinnon, R. D., Kokel, M., and Thomas, J. B. (2003) Nature 422,
583–588
12. Berger, W., Meindl, A., van de Pol, T. J., Cremers, F. P., Ropers, H. H., Doerner, C.,
Monaco, A., Bergen, A. A., Lebo, R., Warburg, M., Zergollern, L., Lorenz, B., Gal, A.,
Bleeker-Wagemakers, E. M., and Meltinger, T. (1992) Nat. Genet. 1, 199–203
13. Chen, Z. Y., Hendriks, R.W., Jobling,M.A., Powell, J. F., Breakefield, X.O., Sims, K. B.,
and Craig, I. W. (1992) Nat. Genet. 1, 204–208
14. Kazanskaya,O., Glinka, A., del BarcoBarrantes, I., Stannek, P., Niehrs, C., andWu,W.
(2004) Dev. Cell 7, 525–534
15. Kim, K. A., Kakitani,M., Zhao, J., Oshima, T., Tang, T., Binnerts,M., Liu, Y., Boyle, B.,
Park, E., Emtage, P., Funk, W. D., and Tomizuka, K. (2005) Science 309, 1256–1259
16. Hsieh, J.-C., Rattner, A., Smallwood, P. M., and Nathans, J. (1999) Proc. Natl. Acad.
Sci. U. S. A. 96, 3546–3551
17. Willert, K., Brown, J. D., Danenberg, E., Duncan, A. W., Weissman, I. L., Reya, T.,
Yates, J. R., III, and Nusse, R. (2003) Nature 423, 448–452
18. Semenov, M. V., Tamai, K., Brott, B. K., Kuhl, M., Sokol, S., and He, X. (2001) Curr.
Biol. 11, 951–961
19. Yoon, J. K., and Wold, B. (2000) Genes Dev. 14, 3204–3214
20. Yoon, J. K., Moon, R. T., and Wold, B. (2000) Dev. Biol. 222, 376–391
21. Kamata, T., Katsube, K., Michikawa, M., Yamada, M., Takada, S., and Mizusawa, H.
(2004) Biochim. Biophys. Acta 1676, 51–62
22. Adams, J. C., and Tucker, R. P. (2000) Dev. Dyn. 218, 280–299
23. Fernig, D. G., and Gallagher, J. T. (1994) Prog. Growth Factor Res. 5, 353–377
24. Takada, S., Stark, K. L., Shea, M. J., Vassileva, G., McMahon, J. A., and McMahon,
A. P. (1994) Genes Dev. 8, 174–189
25. Brigstock, D. R. (2003) J. Endocrinol. 178, 169–175
26. Mercurio, S., Latinkic, B., Itasaki, N., Krumlauf, R., and Smith, J. C. (2004) Develop-
ment (Camb.) 131, 2137–2147
27. Latinkic, B. V., Mercurio, S., Bennett, B., Hirst, E. M., Xu, Q., Lau, L. F., Mohun, T. J.,
and Smith, J. C. (2003) Development (Camb.) 130, 2429–2441
28. Glinka, A., Wu, W., Delius, H., Monaghan, A. P., Blumenstock, C., and Niehrs, C.
(1998) Nature 391, 357–362
29. Mao, B.,Wu,W., Davidson, G.,Marhold, J., Li, M.,Mechler, B.M., Delius, H., Hoppe,
D., Stannek, P., Walter, C., Glinka, A., and Niehrs, C. (2002) Nature 417, 664–667
30. Subramanian, V., Meyer, B. I., and Gruss, P. (1995) Cell 83, 641–653
31. Wilkinson, D. G., Bhatt, S., and Herrmann, B. G. (1990) Nature 343, 657–659
32. Tamai, K., Semenov, M., Kato, Y., Spokony, R., Liu, C., Katsuyama, Y., Hess, F.,
Saint-Jeannet, J. P., and He, X. (2000) Nature 407, 530–535
33. Brennan, K., Gonzalez-Sancho, J. M., Castelo-Soccio, L. A., Howe, L. R., and Brown,
A. M. (2004) Oncogene 23, 4873–4884
34. Tolwinski, N. S., Wehrli, M., Rives, A., Erdeniz, N., DiNardo, S., and Wieschaus, E.
(2003) Dev. Cell 4, 407–418
35. Gonzalez-Sancho, J. M., Brennan, K. R., Castelo-Soccio, L. A., and Brown, A. M.
(2004)Mol. Cell. Biol. 24, 4757–4768
36. Li, L., Mao, J., Sun, L., Liu, W., and Wu, D. (2002) J. Biol. Chem. 277, 5977–5981
37. Kawano, Y., and Kypta, R. (2003) J. Cell Sci. 116, 2627–2634
38. Hsieh, J.-C., Kodjabachian, L., Rebbert, M. L., Rattner, A., Smallwood, P. M., Samos,
C. H., Nusse, R., Dawid, I. B., and Nathans, J. (1999) Nature 398, 431–436
39. Lin, X., and Perrimon, N. (2000)Matrix Biol. 19, 303–307
40. Wiedlocha, A., and Sorensen, V. (2004) Curr. Top. Microbiol. Immunol. 286, 45–79
41. Ai, X., Do, A. T., Lozynska, O., Kusche-Gullberg, M., Lindahl, U., and Emerson, C. P.,
Jr. (2003) J. Cell Biol. 162, 341–351
42. Dhoot,G. K., Gustafsson,M.K., Ai, X., Sun,W., Standiford,D.M., andEmerson, C. P.,
Jr. (2001) Science 293, 1663–1666
43. Tsuda,M., Kamimura, K., Nakato, H., Archer, M., Staatz,W., Fox, B., Humphrey,M.,
Olson, S., Futch, T., Kaluza, V., Siegfried, E., Stam, L., and Selleck, S. B. (1999)Nature
400, 276–280
44. Lin, X. (2004) Development (Camb.) 131, 6009–6021
Cristin/R-spondin Ligands inWnt Signaling
MAY 12, 2006•VOLUME 281•NUMBER 19 JOURNAL OF BIOLOGICAL CHEMISTRY 13257
